P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment
JOURNAL OF THORACIC ONCOLOGY（2019）
关键词
ctDNA,minimal residual disease,circulating tumor DNA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要